The U.S. Food and Drug Administration is investigating whether Fresenius Medical Care, a German-based company that operates and supplies dialysis centers, sat on information suggesting that one of its products carries a potentially lethal risk, according to the New York Times.
Fresenius treats more than a third of the estimated 400,000 Americans who receive dialysis, and is also the country’s leading supplier of dialysis machines and disposable products. It maintains its own clinics, and provides products for other clinics as well.
Last ...
continue reading...
A prominent Wall Street analyst is suggesting that the best way for Johnson & Johnson to cope with its many problems would be to break into smaller companies, according to an article in the Asbury Park Press.
Johnson & Johnson’s Synthes unit, a maker of tools and implants to treat damaged bones, has been sued by the family of a woman who died during an unapproved trial of a bone cement, Bloomberg reports.
